A phase II clinical trial of E7820 for patients with relapsed/refractory myeloid malignancies with mutations in splicing factor genes Meeting Abstract
| Authors: | Bewersdorf, J. P.; Stahl, M. F.; Taylor, J.; Chandhok, N. S.; Watts, J.; Derkach, A.; Wysocki, M.; Kostantakis, V.; Lu, S. X.; Bourcier, J.; Hogg, S.; Totiger, T. M.; Abdel-Wahab, O.; Stein, E. |
| Abstract Title: | A phase II clinical trial of E7820 for patients with relapsed/refractory myeloid malignancies with mutations in splicing factor genes |
| Meeting Title: | 64th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 140 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2022 Dec 10-13 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2022-11-15 |
| Start Page: | 9065 |
| End Page: | 9067 |
| Language: | English |
| ACCESSION: | WOS:000893230302029 |
| DOI: | 10.1182/blood-2022-156830 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
-
342Stein -
573Abdel-Wahab -
100Lu -
148Derkach -
26Hogg -
96Bewersdorf -
10Bourcier -
2Wysocki